CH
CHE.US Chemed Corp
- Market cap
- USD 7.10B
- P/E
- 26.3x
- P/B
- 8.28x
- ROE
- 31.8%
- Dividend yield
- 0.45%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CHE.US undervalued?
Graham numberThe Graham number of Chemed Corp cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Chemed Corp fundamental analysis
No fundamental analysis for Chemed Corp yet.
Chemed Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, i…
Full company profileChemed Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Chemed Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.58B | 1.67B | 1.78B | 1.94B | 2.08B | 2.14B | 2.13B | 2.26B | 2.43B | 2.53B | 2.70B |
| Gross Profit | 461M | 516M | 555M | 617M | 701M | 770M | 765M | 799M | 854M | 758M | 848M |
| Operating Income | 179M | 113M | 244M | 257M | 390M | 343M | 343M | 341M | 366M | 338M | 360M |
| EBITDA | 215M | 157M | 283M | 311M | 455M | 411M | 393M | 414M | 464M | 422M | 432M |
| Net Income | 109M | 98.2M | 206M | 220M | 319M | 269M | 250M | 273M | 302M | 265M | 274M |
| EPS | 6.48 | 5.86 | 12 | 13 | 19 | 17 | 17 | 18 | 20 | 18 | 21 |
| Balance Sheet | |||||||||||
| Total Assets | 880M | 920M | 976M | 1.27B | 1.43B | 1.34B | 1.44B | 1.67B | 1.67B | 1.54B | 1.72B |
| Total Liabilities | 356M | 380M | 384M | 542M | 534M | 719M | 643M | 560M | 550M | 559M | 857M |
| Shareholders' Equity | 524M | 540M | 591M | 727M | 901M | 623M | 799M | 1.11B | 1.12B | 979M | 861M |
| Cash & Short-term Investments | 15.3M | 11.1M | 4.83M | 6.16M | 163M | 32.9M | 74.1M | 264M | 178M | 74.5M | 48.4M |
| Total Debt | 109M | 101M | 103M | 216M | 135M | 324M | 247M | 155M | 141M | 144M | 392M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 135M | 162M | 287M | 301M | 489M | 309M | 310M | 330M | 417M | 388M | 306M |
| Capital Expenditure | 39.8M | 64.3M | 52.9M | 53.0M | 58.8M | 58.7M | 57.3M | 56.9M | 49.5M | 62.8M | 68.5M |
| Free Cash Flow | 95.6M | 98.2M | 234M | 248M | 430M | 250M | 253M | 273M | 368M | 325M | 238M |
| Ratios | |||||||||||
| ROE | 20.7% | 18.2% | 34.8% | 30.3% | 35.4% | 43.1% | 31.3% | 24.6% | 27.0% | 27.1% | 31.8% |
| ROA | 12.4% | 10.7% | 21.1% | 17.3% | 22.3% | 20.0% | 17.3% | 16.3% | 18.1% | 17.2% | 16.0% |
| Net Profit Margin | 6.9% | 5.9% | 11.5% | 11.3% | 15.4% | 12.6% | 11.7% | 12.0% | 12.4% | 10.5% | 10.2% |
| Debt to Equity | 0.21x | 0.19x | 0.17x | 0.30x | 0.15x | 0.52x | 0.31x | 0.14x | 0.13x | 0.15x | 0.46x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Chemed Corp dividends
- Dividend yield
- 0.45%
- Forward dividend
- 2.80 USD
- Payout ratio
- 11.9%
- Ex-dividend date
- Nov 16, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 31.7M | 2.20 | 11.9% |
| 2024 | USD 27.1M | 1.78 | 9.0% |
| 2023 | USD 23.5M | 1.55 | 8.6% |
| 2022 | USD 22.0M | 1.46 | 8.8% |
| 2021 | USD 22.0M | 1.38 | 8.2% |
| 2020 | USD 21.1M | 1.29 | 6.6% |
| 2019 | USD 19.8M | 1.20 | 9.0% |
| 2018 | USD 18.7M | 1.11 | 9.1% |
| 2017 | USD 17.4M | 1.04 | 17.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on May 12, 2005.
Who owns Chemed Corp
- Insiders 1.91%
- Institutions 98.09%
- Public & others 0.00%
- Shares outstanding 13.0M
- Free float 11.8M
Top funds holding CHE.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 470K | 3.63% | +0.05% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 414K | 3.20% | -2.92% | Sep 2026 |
| Vanguard Small Cap Index | 294K | 2.27% | -4.69% | Sep 2026 |
| JHancock Disciplined Value Mid Cap I | 252K | 1.94% | -0.89% | Aug 2026 |
| FullerThaler Behavioral Sm-Cp Eq R6 | 211K | 1.62% | +30.24% | Jun 2026 |
| Vanguard MStar Small Cap Growth Indx Inv | 164K | 1.26% | -7.53% | Sep 2026 |
| JPMorgan Mid Cap Value L | 138K | 1.06% | +0.71% | Sep 2026 |
| Invesco S&P MidCap Quality ETF | 124K | 0.96% | +0.15% | Oct 2026 |
| First Trust SMID Cp Rising Div Achv ETF | 110K | 0.85% | 0.00% | Oct 2026 |
| TD Global Capital Reinvestment - I | 105K | 0.81% | -1.51% | Jun 2026 |
| AQR Long-Short Equity I | 97.3K | 0.75% | +102.15% | Jun 2026 |
| State Street® SPDR® S&P MIDCAP 400® ETF | 96.6K | 0.75% | -0.45% | Sep 2026 |
| Quantex Global Value CHF R | 90.0K | 0.69% | +5.88% | Sep 2026 |
| Strategic Advisers U.S. Total Stock | 86.4K | 0.67% | -2.20% | Sep 2026 |
| Vanguard Dividend Appreciation ETF | 73.9K | 0.57% | -1.61% | Sep 2026 |
| State Street SPDR Port S&P 400 Md CpETF | 71.1K | 0.55% | +0.05% | Oct 2026 |
| Bridge Builder Mid Cap Fund | 68.9K | 0.53% | +626.87% | Oct 2026 |
| Vanguard Equity-Income Inv | 65.4K | 0.50% | 0.00% | Sep 2026 |
| Victory Sycamore Small Company Opp R | 65.0K | 0.50% | -20.73% | Sep 2026 |
| Fidelity Extended Market Index | 59.9K | 0.46% | -7.36% | Sep 2026 |
Top institutions holding CHE.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 1.48M | 11.45% | +11.04% | Jun 2026 |
| AQR Capital Management LLC | 972K | 7.50% | +133.99% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 787K | 6.07% | -3.51% | Jun 2026 |
| Vanguard Capital Management, LLC | 604K | 4.66% | -4.98% | Jun 2026 |
| Acadian Asset Management LLC | 453K | 3.50% | +47.69% | Jun 2026 |
| State Street Corp | 445K | 3.43% | -3.78% | Jun 2026 |
| Geode Capital Management, LLC | 414K | 3.19% | +0.70% | Jun 2026 |
| JPMorgan Chase & Co | 403K | 3.11% | -19.48% | Jun 2026 |
| Boston Partners Global Investors, Inc | 281K | 2.17% | 0.00% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 271K | 2.09% | +4.11% | Sep 2026 |
| TD Global Investment Solutions – TD Epoch | 267K | 2.06% | +6.86% | Jun 2026 |
| TD Asset Management Inc | 256K | 1.98% | -8.38% | Jun 2026 |
| River Road Asset Management, LLC | 238K | 1.84% | +231.52% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 232K | 1.79% | +2.31% | Jun 2026 |
| Fuller & Thaler Asset Management Inc | 220K | 1.70% | +72.68% | Jun 2026 |
| First Trust Advisors L.P. | 220K | 1.70% | -7.02% | Jun 2026 |
| Northern Trust Corp | 199K | 1.54% | +14.02% | Jun 2026 |
| BTIM Corp | 192K | 1.48% | -4.86% | Sep 2026 |
| The Goldman Sachs Group Inc | 184K | 1.42% | +33.29% | Jun 2026 |
| Charles Schwab Investment Management Inc | 170K | 1.31% | +3.87% | Jun 2026 |
Chemed Corp company profile
- Company name
- Chemed Corp
- Ticker
- CHE.US
- Exchange
- USA Stocks
- Listed since
- May 3, 1973
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 15,811
- Fiscal year end
- December
- Address
- 2600 First Financial Center, Cincinnati, OH, United States, 45202-4726
- Phone
- 513 762 6690
- Website
- chemed.com
About Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Chemed Corp management
10- Mr. Kevin J. McNamaraCEO, President & Director · born 1954
- Mr. Michael D. Witzeman CPA, MBAExecutive VP, Controller, Principal Accounting Officer & CFO · born 1971
- Mr. Brian C. Judkins J.D.VP, Secretary & Chief Legal Officer · born 1981
- Mr. Spencer S. LeeExecutive Vice President · born 1956
- Mr. Thomas C. Hutton J.D.VP & Director · born 1951
- Mr. Joel L. WherleyExecutive VP and President & CEO of VITAS Healthcare · born 1965
- Ms. Lisa A. ReinhardVP, Chief Administrative Officer & Assistant Secretary · born 1973
- Ms. Sherri WarnerDirector of Investor Relations
- Mr. Nathan J. McNamaraVP & Chief Strategy Officer · born 1988
- Ms. Holley R. SchmidtVice President & Assistant Controller · born 1972